Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 3/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 7/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4755751 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL1585548 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL1948712 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL2031870 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL4754038 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL4755758 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL4755731 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL2153463 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL4755755 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL4757186 | 1.00 | TSHR (0.52) | TSHRTHRBFAAHTRPV1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1165491-B1 | LTA4 HYDROLASE INHIBITORS | INST NAT SANTE RECH MED (FR) | 2004-02-11 | — | — | EP | claimed |
| JP-2003506317-A | — | — | 2003-02-18 | — | — | JP | claimed |
| EP-1165491-A1 | LTA4 HYDROLASE INHIBITORS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2002-01-02 | — | — | EP | claimed |
| WO-2000059864-A1 | LTA4 HYDROLASE INHIBITORS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2000-10-12 | — | — | WO | claimed |
| CN-118222271-A | Dispersion, composition containing the same, and light conversion layer | DIC株式会社 | 2024-06-21 | — | — | CN | disclosed |
| CN-118222272-A | Dispersion, ink composition containing the same, and light conversion layer | DIC株式会社 | 2024-06-21 | — | — | CN | disclosed |
| CN-105567397-B | Refrigerator oil and working fluid composition for refrigerating machine | 吉坤日矿日石能源株式会社 | 2019-03-08 | — | — | CN | disclosed |
| CN-104788516-A | Microwave synthesis method for dodecyl amino methyl rutin | UNIV SICHUAN | 2015-07-22 | — | — | CN | disclosed |
| US-7964683-B2 | Biocompatible polymeric compound, biocompatible polymer and polymer particles | FUJIFILM CORPORATION (JP) | 2011-06-21 | — | — | US | disclosed |
| CN-101932447-A | Hydrophilic element | FUJIFILM CORP | 2010-12-29 | — | — | CN | disclosed |
| US-20100016534-A1 | BIOCOMPATIBLE POLYMERIC COMPOUND, BIOCOMPATIBLE POLYMER AND POLYMER PARTICLES | FUJIFILM CORPORATION (JP) | 2010-01-21 | — | — | US | disclosed |
| WO-2008110612-A2 | NOVEL COMPOUNDS AND LUBRICATING COMPOSITIONS COMPRISING THE SAME | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2008-09-18 | — | — | WO | disclosed |
| US-6949281-B1 | Varnish composition and liquid-crystal display element | CHISSO CORPORATION (JP) | 2005-09-27 | — | — | US | disclosed |
| EP-1165491-B1 | LTA4 HYDROLASE INHIBITORS | INST NAT SANTE RECH MED (FR) | 2004-02-11 | — | — | EP | disclosed |
| CN-1343216-A | Erythromycin derivatives | HOBURIKU SEIYAKU CO LTD (JP) | 2002-04-03 | — | — | CN | disclosed |
| EP-1165491-A1 | LTA4 HYDROLASE INHIBITORS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2002-01-02 | — | — | EP | disclosed |
| WO-2000059864-A1 | LTA4 HYDROLASE INHIBITORS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2000-10-12 | — | — | WO | disclosed |
| US-4631272-A | N-acylated 1-alkylamino-1-deoxy-ketose derivatives, a process for their preparation and their use | BAYER AKTIENGESELLSCHAFT (DE) | 1986-12-23 | — | — | US | disclosed |
| EP-0152856-A2 | N-acylated 1-alkylamimo-1-desoxy ketose derivatives, method for their preparation and use | BAYER AG (DE) | 1985-08-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100016534-A1 | BIOCOMPATIBLE POLYMERIC COMPOUND, BIOCOMPATIBLE POLYMER AND POLYMER PARTICLES | CD68, ARG1, PUF60 | TSHR 3373/4885THRB 4311/4885FAAH 4134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.